Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

The stem and progenitor cell compartments in low and intermediate-risk myelodysplastic syndromes (MDS) have recently been described, and shown to be highly conserved when compared to those in acute myeloid leukemia (AML). Much less is known about the characteristics of the hematopoietic hierarchy of...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Dimitriou, M, Woll, P, Mortera-Blanco, T, Karimi, M, Wedge, D, Doolittle, H, Douagi, I, Papaemmanuil, E, Jacobsen, S, Hellström-Lindberg, E
Format:	Journal article
Sprache:	English
Veröffentlicht:	Impact Journals 2016

Ähnliche Einträge

Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome
von: M A Pimenova, et al.
Veröffentlicht: (2013-07-01)

A rare case of Fanconi’s anaemia with Myelodysplastic syndrome and complex cytogenetic abnormalities-Monosomy 7 and Down’s syndrome-A case report
von: Rama H, et al.
Veröffentlicht: (2014-08-01)

Progression in patients with low- and intermediate1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
von: Scharenberg, C, et al.
Veröffentlicht: (2016)

Myelodysplastic syndromes
von: Eva Hellström Lindberg
Veröffentlicht: (2018-06-01)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
von: Namik Özbek, et al.
Veröffentlicht: (2015-02-01)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
von: Christian Scharenberg, et al.
Veröffentlicht: (2017-03-01)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
von: Charles Dussiau, et al.
Veröffentlicht: (2023-08-01)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
von: Bingqing Luo, et al.
Veröffentlicht: (2022-05-01)

Cytogenetic clonal evolution In myelodysplastic syndrome
von: Aw, Eunice Ching-Yi
Veröffentlicht: (2018)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
von: Julie Schanz, et al.
Veröffentlicht: (2015-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
von: Mohammad Faizan Zahid, et al.
Veröffentlicht: (2016-12-01)

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
von: Victor B. Pastor, et al.
Veröffentlicht: (2018-03-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
von: Pellagatti, A, et al.
Veröffentlicht: (2009)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
von: Pellagatti, A, et al.
Veröffentlicht: (2010)

Case series: Neurocognitive assessment of three siblings with SAMD9-associated monosomy 7/myelodysplastic syndrome
von: Diana L. Cohen, et al.
Veröffentlicht: (2022-09-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
von: Muneshwar Kumar, et al.
Veröffentlicht: (2019-06-01)

Cytogenetic profile in patients with primary myelodysplastic syndrome
von: S V Gritsaev, et al.
Veröffentlicht: (2013-07-01)

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
von: Gudrun Göhring, et al.
Veröffentlicht: (2011-02-01)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
von: Woll, P, et al.
Veröffentlicht: (2014)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
von: Pellagatti, A, et al.
Veröffentlicht: (2010)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
von: Doolittle, H
Veröffentlicht: (2017)

Myelodysplastic syndromes: moving towards personalized management
von: Eva Hellström-Lindberg, et al.
Veröffentlicht: (2020-07-01)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
von: Woll, P, et al.
Veröffentlicht: (2014)

FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells.
von: Buza-Vidas, N, et al.
Veröffentlicht: (2011)

Molecular Cytogenetics Of Myelodysplastic Syndrome – Hospital Based Study
von: Isa, Asmida
Veröffentlicht: (2014)

Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
von: M. N. Pautova, et al.
Veröffentlicht: (2024-09-01)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
von: Yasser Elnahass, et al.
Veröffentlicht: (2018-03-01)

Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)
von: Tamara Borgonovo, et al.
Veröffentlicht: (2005-12-01)

Computational modeling of stem and progenitor cell kinetics identifies plausible hematopoietic lineage hierarchies
von: Lisa Bast, et al.
Veröffentlicht: (2021-02-01)

Cytogenetic description of breast fibroadenomas: alterations related solely to proliferation?
von: R.R. Burbano, et al.
Veröffentlicht: (2001-08-01)

ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7
von: Meaghan Wall, et al.
Veröffentlicht: (2012-12-01)

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
von: Mohsen Karimi, et al.
Veröffentlicht: (2015-06-01)

Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts
von: Moura, PL, et al.
Veröffentlicht: (2023)

IMPACT PROGNOSIS OF CYTOGENETIC ALTERATIONS IN BRAZILIAN CHILDHOOD MYELODYSPLASTIC NEOPLASM
von: Viviane Lovatel, et al.
Veröffentlicht: (2023-12-01)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
von: Minh Phuong Vu, et al.
Veröffentlicht: (2022-01-01)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
von: Sílvia Saumell, et al.
Veröffentlicht: (2015-01-01)

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast
von: Nida Anwar, et al.
Veröffentlicht: (2017-05-01)

Myelodysplastic syndrome presenting with central diabetes insipidus is associated with monosomy 7, visible or hidden: report of two cases and literature review
von: Yunfan Yang, et al.
Veröffentlicht: (2021-09-01)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
von: Pellagatti, A, et al.
Veröffentlicht: (2017)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
von: Pellagatti, A, et al.
Veröffentlicht: (2013)